Correlation Between Palisade Bio and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Palisade Bio and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palisade Bio and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palisade Bio and CytomX Therapeutics, you can compare the effects of market volatilities on Palisade Bio and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palisade Bio with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palisade Bio and CytomX Therapeutics.
Diversification Opportunities for Palisade Bio and CytomX Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Palisade and CytomX is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Palisade Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palisade Bio are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Palisade Bio i.e., Palisade Bio and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Palisade Bio and CytomX Therapeutics
Given the investment horizon of 90 days Palisade Bio is expected to under-perform the CytomX Therapeutics. In addition to that, Palisade Bio is 1.65 times more volatile than CytomX Therapeutics. It trades about -0.24 of its total potential returns per unit of risk. CytomX Therapeutics is currently generating about -0.14 per unit of volatility. If you would invest 101.00 in CytomX Therapeutics on August 27, 2024 and sell it today you would lose (12.00) from holding CytomX Therapeutics or give up 11.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Palisade Bio vs. CytomX Therapeutics
Performance |
| Timeline |
| Palisade Bio |
| CytomX Therapeutics |
Palisade Bio and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Palisade Bio and CytomX Therapeutics
The main advantage of trading using opposite Palisade Bio and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palisade Bio position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.| Palisade Bio vs. Zura Bio Limited | Palisade Bio vs. Altamira Therapeutics | Palisade Bio vs. Immix Biopharma | Palisade Bio vs. Enveric Biosciences |
| CytomX Therapeutics vs. Eliem Therapeutics | CytomX Therapeutics vs. HCW Biologics | CytomX Therapeutics vs. Scpharmaceuticals | CytomX Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |